Prospect Capital announced it has provided $80.0 million of floating-rate first-lien senior-secured loans and a senior-secured revolving credit facility for the recapitalization of Matrixx Initiatives, owner of Zicam, a developer and marketer of over-the-counter cold remedy products under the Zicam brand. Private equity firm H.I.G. Capital owns a controlling position in Matrixx.

Based in Bridgewater, NJ, Zicam is a top 12 brand in the OTC market and is the number one brand in the cold recovery and cold prevention segment.

Prospect, a business development company, said it has closed more than $1.8 billion of originations to date in the 2013 calendar year. Prospect closed more than $3.0 billion of originations in the twelve months ended June 30, 2013.